Welcome to our Media Room

This page is intended for media-related inquiries and we will be happy to assist and provide current and historical news as well as new developments

Latest News

Forbes
Wall Street Speaks: Eshoo Block Biologics
December 18, 2009
Link to Story

Huffington Post
The Fight For Biogenerics
November 30, 2009
Link to Story

News and Observer
Drug Law Change Could Save Patients Big Bucks
November 29, 2009
Link to Story

The Times Herald
High Cost Of Living
November 1, 2009
Link to Story

CNN
2+ Lobbyist Per Lawmaker
October 22, 2009
Watch the Full Video

Roll Call
Generics Seek New Prescription for Influence
October 14, 2009
Link to Story

USA Today
Twelve Years Of Exclusivity Is Too Many For Pricey Pharmaceuticals
August 12, 2009
Link To Story

The American
Town Hells
August 11, 2009
Link To Story

Washington Post
Biotech Bottleneck
July 28, 2009
Link To Story

Business Week
Biotech: Generics Win A Round
June 29, 2009
Link To Story

Wall Street Journal
FTC: Generic Biologics Won't Erode Competition
June 11, 2009
Link To Story

Reuters
FTC: 12-14 Years too Long To Protect Biotech Drugs
June 10, 2009
Link To Story

Reuters
Us Lawmaker Urges Action On Generic Biotech Drugs
June 8, 2009
Link To Story

New York Times
Slump Pushing Cost Of Drugs Out Of Reach
June 4, 2009
Link To Story

PR Week
Obama's Ambitious Agenda Prompts A Boost In Issues-Based Communications
June 1, 2009
Link To Story

Washington Post
Using Generic Drugs Can Offer Savings - And Do So Safely
May 28, 2009
Link To Story

Miami Herald
Generic Medicines And Their Future
May 18, 2009
Link To Story

Rutland Herald
Curbing Monopolies
May 13, 2009
Link To Story

Chicago Tribune
Europe Jumps Ahead On Cheaper Biotech Drugs
April 30, 2009
Link To Story

Wall Street Journal
Many Drug Prescriptions Are Now Going Unfilled
April 8, 2009
Link To Story

Wall Street Journal Health Blog
More Prescriptions For Generics, Fewer For Branded Drug
April 7, 2009
Link To Story

Patient Centric Healthcare
Teva On Year Of Affordable Healthcare
March 30, 2009
Link To Story

Consumer Reports
Sticker Shock At The Pharmacy Counter
March 19, 2009
Link To Story

Reuters
Us Lawmakers Propose Generic Biotech Drug Plan
March 12, 2009
Link To Story

Inside Health Policy
Waxman Biogenerics Bill Includes Exclusivity, Interchangeability
March 12, 2009
Link To Story

Drug Industry Daily
Rep. Waxman Introduces Biogenerics Legislation
March 11, 2009
Link To Story

Teva Applauds Historic Biotech Competition Legislation
Press Release
March 11, 2009
Read More

Boston Globe
Obama Backing Generic Biologics
February 26, 2009
Link To Story

Wall Street Journal
Sen. Kennedy And Sen. Baucus: We Cannot Delay Health Reform
February 26, 2009
Link To Story

Generic Line
Teva's Marth Discusses FOB, Other Initiatives For 2009
February 18, 2009
Link To Story

The Pink Sheet
Teva's Health Care Reform Campaign Emphasizes Cost Over Expanded Access
February 16, 2009
Link To Story

Fierce Pharma
Teva's Laquinimod For MS Gets Fast Tracked
February 13, 2009
Link To Story

BNA: Pharmaceutical Law & Industry Report
Biotechnology: Teva Urges Congress To Create Approval Pathway For Generic Biologics
February 13, 2009

PR Week
Teva Places '09 As 'Year Of Affordable Healthcare'
February 12, 2009
Link To Story

Drug Store News
Teva Launches Campaign For Affordable Healthcare
February 11, 2009
Link To Story

Drug Industry Daily
Teva Discusses Follow-On Biologics, Initiatives For 2009
February 11, 2009
Link To Story

New York Times
Editorial - (Generic) Drug Resistance
Read More

FDA News
Expert: Seven Years Is Sufficient for Data Exclusivity
Read More

FDA Week
Teva-Funded Study Recommends 7 Years Of Exclusivity For Biologics
Read More

Patent Docs
Former House Ways and Means Economist Claims 7-Year Data Exclusivity Period Is Sufficient
November 20, 2008
Read More

FDA Law Blog
FTC Reveals Agenda for Follow-On Biologics Roundtable
November 20, 2008
Read More

Patent Baristas
Economist Argues That 7 Years Ought to be Enough for Biologic Data Exclusivity
November 20, 2008
Read More

Boston Globe
Clearing the Way for Low Cost Biogenerics
October 27, 2008
Read More

Inside Health Policy
Boston University Study Criticizes Exclusivity Measures In Biogenerics Bills
September 30, 2008
Read More

PharmaTech
Study Promotes Hatch-Waxman Model for Biologics Exclusivity
September 24, 2008
Read More

The Motley Fool
Will Generic Biologics Get Special Treatment
September 23, 2008
Read More

Associated Press
Obama, McCain Advisors Agree... On Generic Drugs
September 18, 2008
Matthew Perrone
Read More

Patent Docs Blog
BU Economics Professor Releases Report on the Impact of Marketing Exclusivity on Biologics Innovation
September 18, 2008
Read More

CQ
Less Is Better On Biologic Exclusivity, Candidates’ Health Advisers Say
September 18, 2008
Read More

FDA News
Study: Hatch Waxman Should Be Model for Biologics Exclusivity
September 18, 2008
Read More

CQ
Report: Increased Competition Will Produce Better, Cheaper Follow-on Biologics
September 17, 2008
Read More

Press Release
Expert Says Eshoo-Barton Bill Stifles Drug Innovation
September 17, 2008
Read More

The Pink Sheet
Teva/Barr Merger Could Spell Opportunity for Smaller Generic Firms
August 25, 2008
Read More

FDA News
Follow-On Biologics Generates Differing Responses
June 25, 2008
Read More

Associated Press
Teva to buy Barr Pharma for more than $7 billion
July 18, 2008
Read More

Barron’s
Barr Acquisition Would Be Beneficial to Teva
July 17, 2008
Read More

New York Times
Patent Law Battle a Boon to Lobbyists
April 30, 2008
Read More

CongressDaily
Generic Drug Group Battle Against Patent Law Change
April 9, 2008
Read More

Drug Topics
GPhA Sets Sights On Increasing Access to Generic Medicine in 2008
March 10, 2008
Read More